Top News

Mymetics announces new collaboration to advance the development of an innovative Malaria vaccine candidate

SBA Member News, 29.11.2014

 Mymetics to apply its innovative virosome vaccine technology to develop a transmissionblocking
Malaria vaccine candidate
 Fully funded by the PATH Malaria Vaccine Initiative (MVI), the study will be developed in
partnership with the Laboratory of Malaria Immunology and Vaccinology (LMIV) of the NIH


GBE: Olefine aus Bakterien

transkript, 28.11.2014

Next Event


Community Login

Bachem Holding AG

 Wissenschaft im Gespraech | Den Naturwissenschaften fehlt der Nachwuchs | Schweizer Radio DRS

The potential in the land

LRC TriCEPS™ technology

BBC - End of Drug Discovery